BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2008
View Archived Issues
Acucela doses first subject in phase I age-related macular degeneration trial
Read More
Genetic cause found for X-linked rare inherited disorder causing epilepsy and mental retardation
Read More
Gene therapy slows neurological decline in children with neuronal ceroid lipofuscinosis
Read More
Protalix to commence open-label extension study for its phase III prGCD trial
Read More
Addex commences phase I interaction study with new ADX-10059 formulation
Read More
MediGene to focus R&D activities on oncology and immunology fields
Read More
GSK exercises right to AM-803 FLAP inhibitor under agreement with Amira
Read More
Santen files Japanese manufacturing and marketing approval applications for DE-089
Read More
Santen enters agreement in Japan and Asia with MacuSight for sirolimus
Read More
Addrenex completes enrollment in U.S. phase III clinical trial of Clonicel in ADHD
Read More
Avexa enters collaboration with TargetDrug for novel lead inhibitors of HCV replication
Read More
Nabi receives a USD 2.5 million milestone payment from Fresenius for CARE-2 study
Read More
Callisto commences phase I trial for constipation and IBD candidate SP-304
Read More
NIAID initiates phase I safety study of Avant's oral ETEC-Cholera vaccine
Read More
Astra Zeneca reports on novel GABA-B agonist candidate for reflux treatment
Read More
Positive first-in-human results for novel multi-CDK inhibitor PHA-848125
Read More
Kyowa Hakko and Kyorin terminate collaborative marketing agreement for Allelock
Read More
Tripep reports positive results from ongoing study of ChronVac-C HCV therapeutic vaccine
Read More
Novartis acquires Protez and North American and European rights to PZ-601 antibiotic
Read More
CHMP issues positive opinion for antibacterial agent Doribax
Read More
Emergent BioSolutions initiates phase II trial for oral typhoid vaccine candidate
Read More
Pharmacopeia identifies new lead compound for advancement under collaboration with GSK
Read More
Recent Purdue Pharma and Neuro Therapeutics patents describe novel analgesic agents
Read More
Recent Biostatin patent discloses novel agents for treating chronic wounds
Read More
New treatment options for gastrointestinal disorders described in recent patents
Read More